
Niagen Bioscience (NASDAQ:NAGE), founded in 1999 and formerly known as ChromaDex, is the global authority on nicotinamide adenine dinucleotide (NAD+), dedicated to advancing healthy-aging science. Our world-renowned scientists collaborate with independent investigators from leading universities and research institutions worldwide to explore the full potential of NAD+, a vital coenzyme found in every cell that declines with age and everyday stressors.
Setting the benchmark as the gold standard in scientific rigor, safety, quality, and transparency, Niagen Bioscience is the innovator behind Niagen (patented nicotinamide riboside, or NR), the most efficient and superior-quality NAD+ booster available. Our ingredient is backed by 35+ human clinical trials and 400+ peer-reviewed studies, making it one of the world’s most extensively researched and validated NAD+ precursors.
We offer two distinct product lines:
Tru Niagen, the number one healthy-aging NAD+ supplement in the United States*, clinically proven to increase NAD+ levels and help people transform the way they age (available at www.truniagen.com)
Niagen Plus, our premium pharmaceutical-grade NAD+ therapy featuring Niagen IV and injectables, available exclusively at clinics with a prescription (www.niagenplus.com)
Our robust patent portfolio protects NR and other NAD+ precursors. As pioneers in NAD+ technology, we continue to demonstrate our commitment to excellence, innovation, and integrity through our two California locations (Tustin and Westwood) and our premier research Laboratory & Innovation Center in Longmont, CO.
Visit www.niagenbioscience.com for press releases, news, and financial information.
Interested in joining our team? Explore career opportunities at https://jobs.lever.co/niagenbioscience
+Based on the top selling dietary supplement brands by revenue per the largest U.S. e-commerce marketplace. (1/1/24-12/31/24)
Up to 90% verified emails and mobile numbers, refreshed weekly.
Niagen Bioscience operates in the Wellness and Fitness Services industry and is headquartered in United States.
Niagen Bioscience has approximately 51-200 employees employees.
Niagen Bioscience is based in Los Angeles, California, United States.
Yes. Niagen Bioscience is a publicly traded company.
You can reach Niagen Bioscience’s investor relations department through the contact section on their official website or directly via the investor relations email listed in their latest SEC filings.
Up to 90% verified emails and mobile numbers, backed by weekly job-change alerts.
An email pattern tells you the format. It does not tell you who works there now or whether an address still delivers. Scalelist returns verified contacts, checked at the point you build the list.
Our team will be in touch soon. If you have any questions, please email us at info@scalelist.com
Just a few more details..
Our team will be in touch soon. If you have any questions, please email us at arnaud@scalelist.com